Johnson and Johnson 2008 Annual Report Download - page 75

Download and view the complete annual report

Please find page 75 of the 2008 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

CORPORATE AND SHAREHOLDER INFORMATION

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(732) 524-0400

The Annual Meeting of Shareholders will take
place April 23, 2009, at the Hyatt Regency
New Brunswick, 2 Albany Street, New Brunswick,
New Jersey. The meeting will convene at 10 a.m.
All shareholders are cordially invited to attend.
A formal Notice of Meeting, Proxy Statement
and Proxy have been sent to shareholders.

Copies of the Company’s 2008 Annual Report
on Form 10-K, Quarterly Reports on Form 10-Q
and Current Reports on Form 8-K to
the Securities and Exchange Commission,
Proxy Statement, and this Annual Report
are available online at www.jnj.com, or to
shareholders without charge upon written
request to the Secretary at the Company’s
principal address or by calling (800) 950-5089.
In addition, on the Company’s
Corporate Governance web site at
www.investor.jnj.com/governance.cfm,
shareholders can see the Company’s
Principles of Corporate Governance,
Charters of the Audit Committee,
Compensation & Benefits Committee
and Nominating & Corporate Governance
Committee, Policy on Business Conduct
for employees and Code of Business
Conduct & Ethics for Members of the Board
of Directors and Executive Ocers.
Copies of these documents are available
to shareholders without charge upon written
request to the Secretary at the Company’s
principal address.
The Company is required to file as an Exhibit
to its Form 10-K for each fiscal year certifica-
tions under Section 302 of the Sarbanes-Oxley
Act signed by the Chief Executive Ocer
and the Chief Financial Ocer. In addition,
the Company is required to submit a certifica-
tion signed by the Chief Executive Ocer
to the New York Stock Exchange within 30 days
following the Annual Meeting of Shareholders.
Copies of the certifications filed for previous
years are posted on the Company’s Corporate
Governance web site, and future certifications
will be posted promptly upon filing.

Listed on New York Stock Exchange
Stock Symbol JNJ

Steven M. Rosenberg
Corporate Secretary
(732) 524-2455

Louise Mehrotra
Vice President, Investor Relations
(800) 950-5089
(732) 524-6492

Questions regarding stock holdings,
certificate replacement/transfer, dividends
and address changes should be directed to:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 328-9033 or
(781) 575-2718 (outside the U.S.)
www.computershare.com

The Plan allows for full or partial
dividend reinvestment, and additional monthly
cash investments up to $50,000 per year,
in Johnson & Johnson common stock without
brokerage commissions or service charges
on stock purchases. If you are interested in
participating in the Plan and need an authoriza-
tion form and/or more information, please call
Computershare Trust Company, N.A.
at (800) 328-9033 or (781) 575-2718
(outside the U.S.).

Shareholders who have inquiries regarding
stock-related matters can communicate directly
with Computershare Trust Company, N.A.
via a telecommunications device (TDD).
The telephone number for this service is
(800) 952-9245 or (781) 575-2692
(outside the U.S.).
Registered shareholders who wish to receive
electronic notice of online access to future
annual reports and proxy materials instead
of paper copies may register online
at www.computershare.com/us/ecomms,
or www.computershare.com/econsent for
employees holding shares in one of the
Johnson & Johnson savings plans.

Company site: www.jnj.com
Johnson & Johnson history:
www.kilmerhouse.com
Blog: www.jnjbtw.com
YouTube: www.youtube.com/JNJhealth
©Johnson & Johnson 2009
The paper used in this publication is made from
30% post-consumer recycled fiber, is Forest Stewardship
Council certified for chain of custody and was
manufactured with green energy credits for purchase
of electricity generated from renewable-energy sources
such as wind and low-impact hydro resources.

1-DAY ACUVUE TRUEYE, ACCESS2WELLNESS, ACIPHEX/PARIET, ACTIVE NATURALS, ACUMINDER, ACUVUE, ACUVUE OASYS, ADVANTAGE, ADVANTAGE BLACKHEAD ERASER, ANIMAS,
AVEENO, AVEENO POSITIVELY AGELESS, BEIJING DABAO COSMETICS COMPANY, BLUE COMET, CENTOCOR, CENTOCOR BIOLOGICS, CHILDREN WITH DIABETES, CILAG AG, CLEAN & CLEAR,
CODMAN & SHURTLEFF, CONCERTA, CONFIDENCE SPINAL CEMENT SYSTEM, CORDIS, CYPHER, CYPHER ELITE, DABAO, DEPUY, DEPUY MITEK, DEPUY ORTHOPAEDICS, DEPUY SPINE,
DIABETES JUVENIL, DOXIL, DURAGESIC, ENSEAL, ETHICON, ETHICON ENDO-SURGERY, EVICEL, EVITHROM, FEVERFEW PFE, GLOBAL PHARMACEUTICAL SUPPLY CHAIN, GRIPTION,
GROUPE VENDOME, HARMONIC, HARMONIC ACE, HARMONIC SYNERGY, HEALTHMEDIA, HUMAN PERFORMANCE INSTITUTE, INTELENCE, INVEGA, JANSSEN CILAG, JOHNSON & JOHNSON,
JOHNSON & JOHNSON CONSUMER COMPANIES, JOHNSON & JOHNSON DIABETES INSTITUTE, JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, JOHNSON & JOHNSON
VISION CARE, JOHNSON’S, LE PETIT MARSEILLAIS, LEVAQUIN/FLOXIN, LGE PERFORMANCE SYSTEMS, LIFESCAN, LISTERINE, LISTERINE TOTAL CARE, MCNEIL-PPC, MEAL MEMORY, MENTOR,
MICRO GROOVES, MINIMED PARADIGM, NAVISTAR THERMOCOOL, NEOSPORIN, NEUTROGENA, NEVER STOP MOVING, NEVO, NUCYNTA, OMRIX BIOPHARMACEUTICALS, ONETOUCH,
ONETOUCH PING, ONETOUCH ULTRALINK, ONETOUCH ULTRAMINI, ONETOUCH VITA, ORTHO-CLINICAL DIAGNOSTICS, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, ORTHO BIOTECH
PRODUCTS, PREZISTA, PROCRIT/EPREX, PURPLE TWILIGHT, REACH, REACH ULTRACLEAN, REALIZE, REALIZE MYSUCCESS, REMICADE, RISPERDAL, RISPERDAL CONSTA, SEDASYS, SIGMA,
SKIN ID, S.M.A.R.T., STELARA, SURGRX, TAXOTERE, THE VISION CARE INSTITUTE, TOPAMAX, TRI-LOCK, TYLENOL, VITROS, ZEFTERA, ZEVTERA, ZYRTEC, ZYRTEC-D

American Diabetes Association, Basilea Pharmaceutica Ltd., Bayer HealthCare AG, The Beijing Organizing Committee for the Games of the XXIX Olympiad, China Qin Shi Huang Terracotta Army
Museum, Forest Stewardship Council, Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria, Grünenthal, Health Care Notication Network, International Olympic Committee
IOC 2008, INSEAD, INTERPHEX, ISPE, Minimed Paradigm (Medtronic MiniMed, Inc.), mothers2mothers, National Psoriasis Foundation, Pharmaceutical Processing, PharmaMar , Project HOPE,
SK Holdings Co. Ltd., UNAIDS, UNICEF, U.S. Food and Drug Administration, Velcade (Millennium: The Takeda Oncology Company)